Right now, nine COVID-19 vaccines are in or near a large-scale human trial phase.
But enrollment of minorities in the trials remains a challenge.
Right now, nine COVID-19 vaccines are in or near a large-scale human trial phase.
But enrollment of minorities in the trials remains a challenge.
Some promising news coming from the Moderna vaccine trial. Researchers say it appears to create a strong immune response in older..
Johnson & Johnson's Covid-19 vaccine candidate begins Phase 3 trials. Veuer’s Maria Mercedes Galuppo has the story.